NovaBay Pharmaceuticals Inc (NBY)
0.085
+0.01
(+10.39%)
USD |
NYAM |
Apr 26, 12:46
NovaBay Pharmaceuticals 1 Year Total Returns (Daily): -94.17% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -94.17% |
April 24, 2024 | -94.52% |
April 23, 2024 | -95.06% |
April 22, 2024 | -95.35% |
April 19, 2024 | -95.12% |
April 18, 2024 | -95.06% |
April 17, 2024 | -95.32% |
April 16, 2024 | -95.58% |
April 15, 2024 | -95.47% |
April 12, 2024 | -93.97% |
April 11, 2024 | -94.33% |
April 10, 2024 | -94.21% |
April 09, 2024 | -94.57% |
April 08, 2024 | -94.24% |
April 05, 2024 | -94.05% |
April 04, 2024 | -93.85% |
April 03, 2024 | -93.97% |
April 02, 2024 | -93.87% |
April 01, 2024 | -93.83% |
March 28, 2024 | -93.50% |
March 27, 2024 | -93.26% |
March 26, 2024 | -90.97% |
March 25, 2024 | -91.63% |
March 22, 2024 | -90.92% |
March 21, 2024 | -91.03% |
Date | Value |
---|---|
March 20, 2024 | -90.14% |
March 19, 2024 | -90.80% |
March 18, 2024 | -90.67% |
March 15, 2024 | -91.03% |
March 14, 2024 | -91.02% |
March 13, 2024 | -90.50% |
March 12, 2024 | -91.58% |
March 11, 2024 | -91.39% |
March 08, 2024 | -92.96% |
March 07, 2024 | -93.00% |
March 06, 2024 | -93.29% |
March 05, 2024 | -93.36% |
March 04, 2024 | -93.27% |
March 01, 2024 | -93.22% |
February 29, 2024 | -93.65% |
February 28, 2024 | -93.30% |
February 27, 2024 | -93.25% |
February 26, 2024 | -93.02% |
February 23, 2024 | -92.90% |
February 22, 2024 | -93.05% |
February 21, 2024 | -93.40% |
February 20, 2024 | -93.19% |
February 16, 2024 | -92.64% |
February 15, 2024 | -93.21% |
February 14, 2024 | -93.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.58%
Minimum
Apr 16 2024
261.7%
Maximum
Mar 16 2021
-44.18%
Average
-62.36%
Median
Aug 01 2022
1 Year Total Returns (Daily) Benchmarks
Eyenovia Inc | -84.23% |
Palatin Technologies Inc | -26.81% |
iBio Inc | -92.77% |
Theriva Biologics Inc | -40.99% |
Oragenics Inc | -65.30% |